# An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures

> **NCT01407523** · PHASE2 · COMPLETED · sponsor: **UCB Japan Co. Ltd.** · enrollment: 16 (actual)

## Conditions studied

- Epilepsy
- Partial Onset Seizures

## Interventions

- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT01407523
- **Lead sponsor:** UCB Japan Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2013-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01407523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01407523, "An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01407523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*